Table 4.
Publication | Type | Application(s) |
---|---|---|
Borodic32 | Case report | Facial lines |
Borodic33 | Case report | Facial lines |
Cohen and Scuderi34 | SR | Glabellar lines; crow’s feet |
Dressler et al19 | Case series | Facial lines (four cases) |
Fabbri et al21 | SR/MA | Ax: glabellar lines |
Tx: dystonia, spasticity, urologic conditions, and hyperhidrosis | ||
Fischer et al35 | Clinical study (interventional) | Facial lines |
Helmstaedter36 | Clinical study (chart review) | Facial lines |
Imhof and Kühne37 | Clinical study (interventional) | Glabellar lines |
Lacroix-Desmazes et al27 | SR | Ax: glabellar lines |
Tx: dystonia, blepharospasm, spasticity, and urological indications | ||
Lawrence and Moy38 | Secondary analysis (safety and efficacy) of clinical trial data | Glabellar lines |
Lee17 | Case report | Masseteric hypertrophy |
Naumann et al22 | SR/MA | Ax: glabellar lines |
Tx: dystonia, urologic conditions, spasticity, and hyperhidrosis | ||
Rahman et al25 | SR/MA | Ax: glabellar lines and crow’s feet |
Tx: dystonia, urological indications, spasticity, facial hemispasm, blepharospasm, and hyperhidrosis | ||
Srinoulprasert et al39 | Clinical study (interventional) | Aesthetic indications (various) |
Stengel and Bee18 | Case report | Glabellar lines |
Stephan et al40 | Case report | Facial lines |
Torres et al41 | Case series | Facial rejuvenation (four cases) |
Wanitphakdeedecha et al42 | Clinical study (interventional) | Aesthetic indications (various) |
Ax, aesthetic indications; Tx, therapeutic indications.